Antisense Treatment of Viral Infection
- 1 January 1994
- book chapter
- Published by Elsevier
- Vol. 44, 267-303
- https://doi.org/10.1016/s0065-3527(08)60331-0
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Ribozymes designed to inhibit transformation of NIH3T3 cells by the activated c-Ha-ras geneGene, 1992
- Preformed ribozyme destroys tumour necrosis factor mRNA in human cellsJournal of Molecular Biology, 1992
- Phosphorothioate oligodeoxynucleotides—anti-sense inhibitors of gene expression?Pharmacology & Therapeutics, 1991
- Herpes simplex virus type-2 ulcers resistant to acyclovir in an AIDS patient — Successful treatment with foscarnetJournal of Molecular Medicine, 1991
- RNA enzymes (ribozymes) as antiviral therapeutic agentsTrends in Biotechnology, 1990
- Antisense RNA production in transgenic miceSomatic Cell and Molecular Genetics, 1990
- Specific inhibition of human immunodeficiency virus type 1 replication by RNA transcribed in sense and antisense orientation from the 5′-leader/gag regionBiochemical and Biophysical Research Communications, 1990
- A new class of antivirals: antisense oligonucleotides combined with a hydrophobic substituent effectively inhibit influenza virus reproduction and synthesis of virus‐specific proteins in MDCK cellsFEBS Letters, 1990
- Inhibition of adenovirus 5 replication in COS-1 cells by antisense RNAs against the viral E1a regionGene, 1989
- Expression of antisense RNA fails to inhibit influenza virus replicationVirus Research, 1989